Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ONI

Request full access

Manufacturer of the next generation of super-resolution microscopes

Oxford, United KingdomFounded 2016Biotech & Life Sciences

About ONI

ONI is a biotechnology company that has developed and commercialized a desktop super-resolution microscope, the Nanoimager, which allows for the visualization and tracking of individual molecules in living cells.

The company's technology is based on a technique called direct Stochastic Optical Reconstruction Microscopy (dSTORM), which enables imaging at a resolution of 20nm. The Nanoimager is a compact and easy-to-use instrument that is designed to be accessible to a broad range of researchers. ONI also offers the Aplo Scope, which combines high-power SMLM imaging with low-power live-cell imaging.

ONI operates in the life sciences and biotechnology markets, serving academic and industrial researchers in fields such as cell biology, immunology, and virology. The company's business model is based on the sale of its microscope instruments, as well as consumables and services. ONI was spun out of Oxford University in 2016 and is headquartered in Oxford, UK, with an office in San Diego, CA.

Source: Dealroom company data

At a glance

Status
Operational
Employees
199
Open positions
None listed
Dealroom signal
73.4/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, Molecular Biology, Spinout, Microscope, Tech for Biotech and Pharma, Tech for Hospitals and Clinics
Technology
Hardware, Deep Tech, Nanotech
Business model
Manufacturing
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Jan 2022 $75M $300M Casdin Capital · ARCH Venture Partners · Axon Ventures · Oxford Science Enterprises ↗
SERIES AOther financing Mar 2018 $24M $96M Casdin Capital · Oxford Science Enterprises —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

ONI website traffic

Latest recorded traffic for ONI is 47K monthly website visits, up 213.3% over the last three months. ONI's team grew 2.1% over the past year.

Latest monthly visits47K 3-month web change+213.3% 1-year team growth+2.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
CardiaTecApplying artificial intelligence on large-scale human multiomic data to develop the next generation of cardiovascular disease targets Cambridge, United Kingdom Operational 17 $8.7M $26M
PharmEnablePharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery Cambridge, United Kingdom Operational
OMass TherapeuticsA drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets Oxford, United Kingdom Operational
PhoreMostA new-model drug discovery company based in Cambridge, UK Pampisford, United Kingdom Operational
HealxAI-drug discovery accelerating treatments for rare diseases Cambridge, United Kingdom Operational
OXGENECombination of precision engineering and breakthrough science, together with advanced robotics and bioinformatics, accelerates the rational design, discovery and manufacture of cell and gene therapies Oxford, United Kingdom Acquired
ExscientiaApplying artificial intelligence and big data processing to accelerate discovery and development of drugs Oxford, United Kingdom Acquired
OptellumDeveloping an artificial intelligence software platform to support clinicians in lung cancer nodule management Oxford, United Kingdom Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

ONI in the Oxford ecosystem

Live from Dealroom

The ONI office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Oxford Science Enterprises
  • GT Healthcare

Series A7 investors entered at this stage

Other known investors2 additional known investors

  • Oxford University Innovation
  • University of Oxford
Team profiled 17 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
10 countries with
team presence
🇺🇸 United States44.7%
🇬🇧 United Kingdom42.1%
🇩🇪 Germany2.6%
🇳🇱 Netherlands2.6%
🇪🇸 Spain1.3%
Top 5 of 10 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about ONI on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ONI’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.